Glass House Brands Goes Medical-Cannabis Only In Preparation For Uplisting

Following an established script, another publicly traded cannabis operator has separated its medical marijuana from its adult-use holdings in a bid to uplist on the New York Stock Exchange.

But California-based vertically integrated operator Glass House Brands said in documents filed Thursday that it plans to go beyond uplisting to the NYSE. Specifically, the company said it’s preparing to for export and interstate commerce.

The company previously said in a press release Wednesday it’s applied to list on the NYSE after “segregating” its medical and adult-use businesses.

If successful, Glass House would become the second U.S.-based cannabis company to list on a major mainstream American exchange after Florida-based marijuana multistate operator Trulieve Cannabis Corp.

To Read The Rest Of This Article On MJ Biz Daily, Click Here

The post Glass House Brands Goes Medical-Cannabis Only In Preparation For Uplisting appeared first on Marijuana Retail Report – News and Information for Cannabis Retailers.